Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Blue Owl Technology Finance 452M Shares Outstanding Q3 2026

Blue Owl Technology Finance Corp. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 4, 2026, covering the fiscal quarter ended September 30, 2026.

Anjali Anand | 04 November 2026

Edgewise Therapeutics Q3 2026: 109.5M Shares Outstanding

Edgewise Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 4, 2026, disclosing operational and financial information for the third quarter of fiscal year 2026.

Anjali Anand | 04 November 2026

ARKO Petroleum Files Q3 2026 Report With 12.57M Class A Shares

ARKO Petroleum Corp. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 4, 2026, covering the fiscal quarter ended September 30, 2026.

Aakashdeep | 04 November 2026

Viper Energy Q3 2026 10-Q: 192.7M Class A Shares Outstanding

Viper Energy, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing share counts, capital structure details, and financial results for the third quarter of 2026.

Manish Choudhary | 04 November 2026

Xencor Q3 2026: Total Assets Fall to $770.5M

Xencor, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the fiscal quarter ended September 30, 2026, disclosing a consolidated balance sheet reflecting a decline in total assets from $875.5 million at year-end 2025 to $770.5 million.

Aakashdeep | 04 November 2026

Winchester Bancorp Q1 FY2027: Net Income Rises to $1.27M

Winchester Bancorp, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the three months ended September 30, 2026, reporting net income of $1.268 million on total assets of $1.141 billion.

Vinay Lochav | 04 November 2026

Arcutis CEO Watanabe Sells 4,377 Shares for Tax Withholding

Todd Watanabe, President and Chief Executive Officer of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), filed a Form 4 on November 4, 2026, disclosing the sale of 4,377 shares of common stock on November 2, 2026, to cover tax withholding obligations related to the vesting of Restricted …

Manish Choudhary | 04 November 2026

Robert A. Scott Reports 17,523 Arcutis Shares via Family Trust

An amended initial statement of beneficial ownership was filed on November 4, 2026, disclosing director Robert A. Scott's holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) as of the event date of October 23, 2026.

Vinay Lochav | 04 November 2026

Patrick Burnett Sells 943 Arcutis Shares for Tax Withholding

Patrick Burnett, EVP and Chief Medical Officer of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), filed a Form 4 on November 4, 2026, disclosing the sale of 943 shares of common stock on November 2, 2026, to cover tax withholding obligations arising from the vesting of Restricted …

Nitish Kishor | 04 November 2026

Personalis CEO Hall Sells 29,112 Shares at $15.87

Christopher M. Hall, Chief Executive Officer and Director of Personalis, Inc., filed a statement of changes in beneficial ownership on November 4, 2026, disclosing a sale of 29,112 shares of common stock on November 3, 2026.

Aakashdeep | 04 November 2026
Support

Hi! How can we help you today?

Loading…